1. Home
  2. SPRY vs OPRA Comparison

SPRY vs OPRA Comparison

Compare SPRY & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • OPRA
  • Stock Information
  • Founded
  • SPRY 2015
  • OPRA 1996
  • Country
  • SPRY United States
  • OPRA Norway
  • Employees
  • SPRY 160
  • OPRA N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • OPRA Computer Software: Prepackaged Software
  • Sector
  • SPRY Health Care
  • OPRA Technology
  • Exchange
  • SPRY Nasdaq
  • OPRA Nasdaq
  • Market Cap
  • SPRY 1.4B
  • OPRA 1.3B
  • IPO Year
  • SPRY N/A
  • OPRA 2018
  • Fundamental
  • Price
  • SPRY $13.44
  • OPRA $16.98
  • Analyst Decision
  • SPRY Strong Buy
  • OPRA Strong Buy
  • Analyst Count
  • SPRY 4
  • OPRA 5
  • Target Price
  • SPRY $28.75
  • OPRA $24.90
  • AVG Volume (30 Days)
  • SPRY 1.2M
  • OPRA 583.6K
  • Earning Date
  • SPRY 05-14-2025
  • OPRA 04-28-2025
  • Dividend Yield
  • SPRY N/A
  • OPRA 4.71%
  • EPS Growth
  • SPRY N/A
  • OPRA N/A
  • EPS
  • SPRY 0.08
  • OPRA 0.93
  • Revenue
  • SPRY $89,149,000.00
  • OPRA $521,494,000.00
  • Revenue This Year
  • SPRY $1.49
  • OPRA $20.00
  • Revenue Next Year
  • SPRY $141.68
  • OPRA $15.66
  • P/E Ratio
  • SPRY $168.00
  • OPRA $18.27
  • Revenue Growth
  • SPRY 297063.34
  • OPRA 26.68
  • 52 Week Low
  • SPRY $7.55
  • OPRA $10.11
  • 52 Week High
  • SPRY $18.51
  • OPRA $22.50
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 46.69
  • OPRA 56.07
  • Support Level
  • SPRY $13.06
  • OPRA $17.01
  • Resistance Level
  • SPRY $15.06
  • OPRA $17.62
  • Average True Range (ATR)
  • SPRY 0.67
  • OPRA 0.63
  • MACD
  • SPRY -0.18
  • OPRA 0.23
  • Stochastic Oscillator
  • SPRY 15.97
  • OPRA 81.89

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

Share on Social Networks: